Dentsu Group (4324) Q2 2025 earnings summary

Executive summary

• H1 FY2025 organic growth rate was -0.2%, slightly below expectations due to international business challenges, while Japan delivered record-high net revenue and profit.

• Underlying operating profit increased 7.2% year-over-year to ¥67.5 billion, with operating margin up to 12.0%, exceeding expectations.

• Goodwill impairment loss of ¥86 billion was recorded in the Americas and EMEA, resulting in a statutory net loss.

• Interim dividend suspended and year-end dividend forecast undetermined to prioritize capital enhancement and due to valuation losses.

• Strategic measures include cost reductions, headcount cuts, and expedited review of international business to restore profitability.

Financial highlights

• Consolidated net revenue for H1 FY2025 was ¥562.0 billion, down 2.1% year-over-year; underlying operating profit rose to ¥67.5 billion (+7.2%).

• Statutory operating loss was ¥36.5 billion and net loss was ¥73.6 billion, mainly due to impairment.

• Underlying net profit was ¥32.4 billion, nearly flat year-over-year; basic EPS was negative ¥283.72.

• EBITDA for H1 FY2025 was ¥73.2 billion, up 5.5% year-over-year.

• Net cash flow from operating activities improved to ¥37.0 billion from negative ¥71.6 billion year-over-year.

Outlook and guidance

• Full-year 2025 organic growth guidance revised to approximately 0%, with operating margin maintained at around 12%.

• Full-year net revenue forecast lowered to ¥1,180.1 billion, underlying operating profit to ¥141.6 billion, and net loss projected at ¥75.4 billion.

• Japan organic growth guidance maintained at circa 3%; international business revised to negative circa 2%.

• Dividend per share forecast is currently undetermined.